Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Kate Hanna, spokesperson for Novo Nordisk Canada, said in an emailed statement on Tuesday that the company is considering introducing a version of semaglutide to compete with generics once they enter the Canadian market. Mina Tadrous, a pharmaceutical policy expert at the University of Toronto, called the potential move an interesting play. Because of the pricing structure (in Canada) they cant really just lower the price of their brand-name product to allow generic market entry
This is a serious warning sign
D 74 , 531544 (2018)
We take a holistic approach, integrating medication, diet, exercise, and behavioral changes to ensure long-term success
US$ 22.12
US$ 25.38
.webp)
US$ 22.52
US$ 22.88
US$ 29.57
US$ 25.22
US$ 23.22
US$ 28.74
